This article, which originally appeared on the Duke Cancer Institute Blog can only be accessed via The Wayback Machine at this link. Below are screenshots of the original.

In December 2023 and January 2024 Duke Cancer Institute senior leaders surprised three deserving recipients with the coveted DCI Superstar Award in recognition of their achievements and exceptional service in going above and beyond in their work.

Brent Hanks, MD, PhD, is working to develop new pharmacologic and genetic strategies to overcome immunotherapy resistance and investigating the mechanisms that contribute to some immunotherapy-associated toxicities.

Community members, including cancer survivors and caregivers, learned about the latest clinical advances in treating kidney, prostate, and bladder cancers. In addition, the 50-year career of urologist William Berry, MD, was honored.

MD & MDiv grad Monica Bodd thinks a lot about the patient experience and how to make it better — both through research and clinical practice. You can take the doctor out of Duke, but you can't take Duke out of the doctor.

This spring, the "Andrew Berchuck, MD, Gynecologic Oncology Endowed Lectureship" was established in celebration of Dr. Berchuck's "remarkable legacy to the subspecialty of gynecologic oncology and to training the next generation of physicians."

As the 2023 Annual Meeting of the American Society of Clinical Oncology was wrapping up this week, Chief Patient Experience and Safety Officer at Duke Cancer Institute Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO, was already in planning mode.

Angeles Alvarez Secord, MD, MHSc, was officially installed as president of the Society of Gynecologic Oncology at the Society's Annual Meeting, held in March. Her term lasts for a year.

Betty Tong, MD, BME, MSME, MD, MHS, is a recipient of the inaugural “Extraordinary Women in Cardiothoracic Surgery Award” established by the Society of Thoracic Surgeons and Women in Thoracic Surgery.

DCI leadership has presented the coveted DCI Superstar Achievement Awards once again. The annual event celebrates and recognizes the achievements and exceptional service of DCI faculty, providers, and staff.

“Susan is the ultimate professional and her contribution to the clinical research of the PRTBTC was a foundation for the breadth and success of our efforts to translate high quality science into the clinic."

After 32 years of compassionate service to the Duke University Health System, including the past 10 years as the Chief Human Resource Officer at Duke Cancer Institute, LeAnn Hinson, RN, MSN, has announced her retirement.

“Evelyn gave nurses a place, ‘not behind, always in front,’ to advocate for oncology patients. She developed the first guidelines for oncology patients for the treatment of mucositis and stomatitis. Evelyn was very proud of that."

In a lot of ways, Susan Blackwell (Crawford), MHS, PA-C’89, and the physician assistant profession have grown up together.

More than 1.5 million women in the U.S. are currently on endocrine therapies (hormone therapies) for breast cancer. These drugs and drug combinations have been found to work well, in some cases for many years, until they don’t.

The Radiation Research Society has bestowed its highest honor — the Failla Memorial Lecture Award — on Michael B. Kastan, MD, PhD, executive director of Duke Cancer Institute and William and Jane Shingleton Professor, Pharmacology and Cancer Biology.

Gloria Johnson Bass, MA, received the 2022 Susan B. Clark Administrative Leadership Award who's been "part of the Duke Health family for 41 years, and has grown her career here at Duke taking on roles with increasing responsibility."

Joseph Odell Moore, MD, celebrated his 75th birthday, and after 44 years, retired from clinical practice as a DCI hematologic oncologist.

Deputy Director of Duke Cancer Institute Steven Patierno, PhD, is energized by his decades-long work in cancer control and cancer health disparities.